Cancer treatment
Scientists in Australia have discovered a promising new biomarker and treatment target for ovarian cancer, which could potentially improve the outlook for women diagnosed with this aggressive disease. Ovarian cancer is the deadliest gynecological cancer worldwide, with poor survival rates largely due to late diagnosis. The researchers have identified a
Cancer research
A team of researchers from the University of Florida and the University of Texas MD Anderson Cancer Center has discovered that mRNA vaccines, widely used to combat COVID-19, may also enhance the immune system's ability to recognize and attack cancer tumours. Studying medical records of cancer patients who
Apoptosis
Researchers at Daegu Catholic University in Gyeongsan, South Korea, have made a breakthrough discovery in the fight against ovarian cancer. The team found that a compound called corylin, derived from the fruit of a plant, exhibits significant anticancer activity by inducing apoptosis and cell cycle arrest in ovarian cancer cells.
Cancer research
A team of researchers from the University of Florida and the University of Texas MD Anderson Cancer Center has discovered that mRNA vaccines, widely used to combat COVID-19, may also enhance the immune system's ability to recognize and attack cancer tumours. Studying medical records of cancer patients who
Cancer patients
Researchers from the University of Florida and the University of Texas MD Anderson Cancer Center have made a groundbreaking discovery linking the COVID-19 mRNA vaccine to significantly improved survival outcomes in patients with advanced lung and skin cancer. The study finds that patients who received the COVID-19 mRNA vaccine within
Cancer treatment
Vinmec International Hospital, a leading healthcare provider in Vietnam, has gained international recognition for its innovative approach to cancer treatment using autologous cell-based AIET immunotherapy. This technology, transferred from GN Corporation, Japan, has been implemented in accordance with Japanese regulations and has resulted in significantly extended survival and improved quality
Cancer prevention
As intermittent fasting gains popularity, cancer patients are often drawn to its potential role in cancer prevention and treatment. However, this trend has led to numerous misconceptions that can be detrimental to those seeking scientifically-backed care. Dr. Sudipto De, a robotic cancer surgeon specializing in genetics and onco-nutrition, is shedding
Cancer
In response to the COVID-19 pandemic, guidelines for hypofractionated radiation therapy (hRT) regimens were published to minimize patient exposure, ensure staff safety, and conserve healthcare resources. Research conducted by the University of Texas MD Anderson Cancer Center in collaboration with the International Lymphoma Radiation Oncology Group (ILROG) aimed to evaluate
Cancer prevention
As intermittent fasting gains popularity, cancer patients are often drawn to its potential role in cancer prevention and treatment. However, this trend has led to numerous misconceptions that can be detrimental to those seeking scientifically-backed care. Dr. Sudipto De, a robotic cancer surgeon specializing in genetics and onco-nutrition, is shedding
Cancer treatment
Preliminary research published in the journal Nature has found that patients with advanced lung or skin cancer who received an mRNA COVID vaccine within 100 days of starting immunotherapy lived significantly longer than those who didn't. Researchers suggest that the mRNA molecule in the vaccines acts as an
Breast cancer
Researchers at the University of Pennsylvania have made a groundbreaking discovery in cancer treatment by identifying and targeting dormant "sleeper cells" that can cause breast cancer to return and spread years after the original tumor is removed. This innovative approach, led by oncologist Dr. Angela DeMichele, has shown
Cancer research
A groundbreaking study published in the journal Nature suggests that COVID-19 mRNA vaccines could have a profound impact on cancer treatment, potentially leading to improved survival rates and extended benefits of immunotherapy for millions of patients. The research findings, led by pediatric oncologist Elias Sayour, reveal that patients who received
